APA (7th ed.) Citation

MJ, P., J, C., J, N., E, G., B, G., M, M., . . . JL, G. (2026). Impact of intravenous ferric carboxymaltose on physical performance and patient-reported outcomes in elderly patients with non-dialysis CKD, mild anemia, and iron deficiency: A pilot study. Nefrologia, 46(2), 501418. https://doi.org/10.1016/j.nefroe.2026.501418

Chicago Style (17th ed.) Citation

MJ, Puchades, et al. "Impact of Intravenous Ferric Carboxymaltose on Physical Performance and Patient-reported Outcomes in Elderly Patients with Non-dialysis CKD, Mild Anemia, and Iron Deficiency: A Pilot Study." Nefrologia 46, no. 2 (2026): 501418. https://doi.org/10.1016/j.nefroe.2026.501418.

MLA (9th ed.) Citation

MJ, Puchades, et al. "Impact of Intravenous Ferric Carboxymaltose on Physical Performance and Patient-reported Outcomes in Elderly Patients with Non-dialysis CKD, Mild Anemia, and Iron Deficiency: A Pilot Study." Nefrologia, vol. 46, no. 2, 2026, p. 501418, https://doi.org/10.1016/j.nefroe.2026.501418.